| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |